What is the latest news on BTX?

In the last 30 days Quantisnow tracked 1 wire item for BTX: 1 dividend update. The most recent was published on October 30, 2026.

Where does BTX stock trade?

BlackRock Technology and Private Equity Term Trust (BTX) is listed on NYSE.

What are analysts saying about BTX?

BlackRock Technology and Private Equity Term Trust has had 2 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight with a $9.00 price target on 2021-12-29. Recent price targets range from $9.00 to $20.00.

What companies are similar to BTX?

Notable peers in the same industry include CADL (Candel Therapeutics Inc.), REPL (Replimune Group Inc.), AGEN (Agenus Inc.), IOVA (Iovance Biotherapeutics Inc.). Compare BTX side-by-side with any of them on Quantisnow.

How can I track BTX on Quantisnow?

Quantisnow aggregates BlackRock Technology and Private Equity Term Trust's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BTX to receive live email and push alerts on every new disclosure.

BTX

NYSE

BlackRock Technology and Private Equity Term Trust

IPO2021

Follow + get alerts

Website

BlackRock Technology and Private Equity Term Trust (BTX) is a public company listed on NYSE. In the last 30 days Quantisnow tracked 1 wire item for BTX, including 1 dividend update. The most recent was published Oct 30, 2026.

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company is based in Brooklyn, New York.

BTX rankings

News · 26 weeks14-50%

2026-05-172026-11-08

Mix890d

Dividends4(50%)
Other3(38%)
Insider1(13%)

Activity · 52 weeks3028 active days

Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

BTX FAQ

7 questions

What does BlackRock Technology and Private Equity Term Trust do?
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company is based in Brooklyn, New York.
What is the latest news on BTX?
In the last 30 days Quantisnow tracked 1 wire item for BTX: 1 dividend update. The most recent was published on October 30, 2026.
Where does BTX stock trade?
BlackRock Technology and Private Equity Term Trust (BTX) is listed on NYSE.
When did BlackRock Technology and Private Equity Term Trust go public?
BlackRock Technology and Private Equity Term Trust (BTX) completed its IPO in 2021.
What are analysts saying about BTX?
BlackRock Technology and Private Equity Term Trust has had 2 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight with a $9.00 price target on 2021-12-29. Recent price targets range from $9.00 to $20.00.
What companies are similar to BTX?
Notable peers in the same industry include CADL (Candel Therapeutics Inc.), REPL (Replimune Group Inc.), AGEN (Agenus Inc.), IOVA (Iovance Biotherapeutics Inc.). Compare BTX side-by-side with any of them on Quantisnow.
How can I track BTX on Quantisnow?
Quantisnow aggregates BlackRock Technology and Private Equity Term Trust's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BTX to receive live email and push alerts on every new disclosure.